Cervical Cancer
Shivapurkar N, Sherman ME, Stastny V, Echebiri C, Rader JS, Nayar R, Bonfiglio TA, Gazdar AF, Wang SS.
Evaluation of candidate methylation markers to detect cervical neoplasia.
Gynecol Oncol. 2007;107(3):549-53.
Feng Q, Hawes SE, Stern JE, Dem A, Sow PS, Dembele B, Toure P, Sova P, Laird PW, Kiviat NB.
Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia.
Cancer Epidemiol Biomarkers Prev. 2007;16(6):1178-84.
Jeong DH, Youm MY, Kim YN, Lee KB, Sung MS, Yoon HK, Kim KT.
Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics.
Int J Gynecol Cancer. 2006;16(3):1234-40.
Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ, Boezen HM, Hollema H, Schuuring E, Sidransky D, van der Zee AG.
Assessment of gene promoter hypermethylation for detection of cervical neoplasia.
Int J Cancer. 2006;119(8):1908-14.
Additional Publications
Kang S, Kim JW, Kang GH, Lee S, Park NH, Song YS, Park SY, Kang SB, Lee HP.
Comparison of DNA hypermethylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.
Int J Cancer. 2005 Dec 5; [Epub ahead of print]
Duenas-Gonzalez A, Lizano M, Candelaria M, Cetina L, Arce C, Cervera E.
Epigenetics of cervical cancer. An overview and therapeutic perspectives.
Mol Cancer. 2005;4(1):38
Reesink-Peters N, Wisman GB, Jeronimo C, Tokumaru CY, Cohen Y, Dong SM, Klip HG, Buikema HJ, Suurmeijer AJ, Hollema H, Boezen HM, Sidransky D, van der Zee AG.
Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study.
Mol Cancer Res. 2004;2(5):289-95.
Jeong DH, Youm MY, Kim YN, Lee KB, Sung MS, Yoon HK, Kim KT.
Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics.
Int J Gynecol Cancer. 2006;16(3):1234-40.
Lin Z, Gao M, Zhang X, Kim YS, Lee ES, Kim HK, Kim I.
The hypermethylation and protein expression of p16 INK4A and DNA repair gene O 6-methylguanine-DNA methyltransferase in various uterine cervical lesions.
J Cancer Res Clin Oncol. 2005;131(6):364-70. Epub 2005 Mar 23.
Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, Dembele B, Critchlow CW, Xi L, Lu H, McIntosh MW, Young AM, Kiviat NB.
Detection of hypermethylated genes in women with and without cervical neoplasia.
J Natl Cancer Inst. 2005;97(4):273-82.
Muller HM, Widschwendter A, Fiegl H, Goebel G, Wiedemair A, Muller-Holzner E, Marth C, Widschwendter M.
A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer.
Cancer Lett. 2004;209(2):231-6.
Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LS, Li BF, Bernard HU.
The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation.
Virology. 2004;324(2):483-92.
Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Lie K, Barrera-Saldana HA, Wiley DJ, Bernard HU.
Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia.
J Virol. 2004;78(23):12762-72.
Yu MY, Tong JH, Chan PK, Lee TL, Chan MW, Chan AW, Lo KW, To KF.
Hypermethylation of the tumor suppressor gene RASSF1Aand frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Int J Cancer 2003;105(2):204-9